Loading organizations...
§ Venture Capital · Antwerp, Antwerpen, Belgium
Government-backed venture capital fund for biotech & life sciences in Flanders, Belgium. Early-stage equity.
Biotech Fund Flanders functions as a specialized venture capital fund, providing strategic capital to foster growth for biotech companies within Belgium's Flanders region. It primarily deploys capital through co-investment, accelerating development and commercialization of innovative life science technologies. The fund's objective is to bolster the Flemish life sciences sector with targeted financial support.
Established to stimulate the Flemish biotech industry, Biotech Fund Flanders was initially managed by GIMV, a European investment company. Management later transitioned to PMV, a regional investment firm. This progression reflects the insight that dedicated financial instruments are crucial for cultivating a competitive biotech landscape and sustaining regional innovation.
The fund targets biotech enterprises in Flanders, delivering essential venture capital for their advancement. Its vision centers on reinforcing Flanders' position as a premier life sciences hub, fostering an ecosystem where scientific discoveries evolve into impactful commercial successes. The fund commits to driving long-term economic progress across the region.
Biotech Fund Flanders has 1 tracked investment across 1 company. The latest tracked deal is $15.6M Series B in Complix in June 2013.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jun 26, 2013 | Complix | $15.6M Series B | Biotech Fund Flanders, Patrick VAN Beneden | Baekeland II Fund, CRP Sant, Gemma Frisius Fund, LRM, Omnes Capital, Trustcapital, Vesalius Biocapital, Vinnof |